A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

293

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

April 30, 2013

Conditions
Hypertension
Interventions
DRUG

Placebo

Placebo

DRUG

Valsartan

Valsartan 80mg

DRUG

Fimasartan

Fimasartan 30mg

Trial Locations (1)

Unknown

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

Bucheon St. Mary's Hospital

OTHER

collaborator

Konyang University Hospital

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

National Health Insurance Service Ilsan Hospital

OTHER

collaborator

Daegu Fatima Hospital

OTHER

collaborator

Dong-A University

OTHER

collaborator

Soon Chun Hyang University

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Gangnam Severance Hospital

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Ulsan University Hospital

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Sejong General Hospital

OTHER

collaborator

Ewha Womans University Mokdong Hospital

OTHER

collaborator

Jeju National University Hospital

OTHER

collaborator

Hallym University Medical Center

OTHER

collaborator

Hanyang University

OTHER

lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY